Bone Growth Stimulators Industry Forecast: $1.94 Billion by 2030

Bone Growth Stimulators Industry Forecast: $1.94 Billion by 2030

Bone Growth StimulatorsMarket2023-2030 Meticulous Research , a leading market research firm, has released a new report titled Bone Growth Stimulators Market by Product (Stimulation Device [External, Ultrasonic, Implantable], Bone Morphogenetic Proteins, Platelet-Rich Plasma), Application (Spinal Fusion, Fracture, Oral Surgeries), End User (Hospital, ASC) - Global Forecast to 2030. Download Free Sample Report: https://www.meticulousresearch.com/download-sample- report/cp_id=3530?utm_source=pdf&utm_medium=social&utm_campaign=product&utm _content=18-06-2024 According to the report, the global bone growth stimulators market is expected to reach $1.94 billion by 2030, growing at a CAGR of 4.9% from 2023 to 2030. Key drivers of this growth include a rising preference for minimally invasive treatments, an increase in bone fractures and spinal injuries, a growing elderly population leading to more orthopedic conditions, and a surge in sports injuries. The market also benefits from the expansion of hospitals and surgical centers, wider use of platelet-rich plasma (PRP), and growth in emerging economies. Market Segmentation: By Product: Bone Growth Stimulation Devices: External Bone Growth Stimulators (Capacitive Coupling Devices, Combined Magnetic Field Devices, Pulsed Electromagnetic Field Devices), Ultrasonic Bone Growth Stimulators, Implantable Bone Growth Stimulators Bone Morphogenetic Proteins Platelet-Rich Plasma By Application: Spinal Fusion Surgeries Union & Non-union Bone Fractures Oral and Maxillofacial Surgeries Other Applications By End User: Hospitals & Specialized Clinics Ambulatory Surgery Centers (ASC) Other End Users Geography: North America Europe Asia-Pacific Latin America Middle East & Africa Page 1 of 3 Meticulous Research| sales@meticulousresearch.com

Bone Growth StimulatorsMarket2023-2030 Browse in Depth: https://www.meticulousresearch.com/product/bone-growth-stimulator- market- 3530?utm_source=pdf&utm_medium=social&utm_campaign=product&utm_content=18- 06-2024 Key Findings: Product Insights: The bone growth stimulation devices segment is expected to lead the market in 2023, driven by increasing cases of bone fractures, demand for cost-effective and less painful treatments, and a preference for non-invasive surgical procedures. Application Insights: The delayed union & non-union bone fractures segment is projected to have the highest CAGR during the forecast period due to the rising incidence of bone fractures among the elderly and osteoporosis-related conditions. End User Insights: Hospitals and specialized clinics are anticipated to hold the largest market share in 2023, attributed to the widespread availability of hospitals, increasing patient visits, and a growing number of medical professionals. Geographical Insights: North America is expected to lead the market in 2023, due to high healthcare expenditure, a growing elderly population, technological advancements, and early adoption of innovative healthcare products. Market Drivers: Minimally Invasive Treatments: Increasing patient preference for treatments that reduce recovery time and pain. Orthopedic Conditions: Rising incidences of bone fractures, spinal injuries, and sports injuries. Geriatric Population: An aging population leading to more cases of orthopedic diseases. Healthcare Infrastructure: Growth in the number of hospitals and surgical centers, especially in emerging economies. Technological Advancements: Enhanced efficacy of bone growth stimulators through innovative technologies. Opportunities: Emerging markets, increased application of PRP in various treatments, and the growing healthcare infrastructure present significant growth opportunities for market players. Key Players: Leading companies in the bone growth stimulators market include Orthofix Medical Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Medtronic, plc (Ireland), Stryker Corporation (U.S.), Johnson & Johnson Private Limited (U.S.), DJO, LLC (U.S.), Bioventus LLC (U.S.), OssaTechnics BV (Germany), Arthrex GmbH (U.S.), Smith & Nephew plc (U.K.), and ITO CO., Ltd. (Japan). Page 2 of 3 Meticulous Research| sales@meticulousresearch.com

Bone Growth StimulatorsMarket2023-2030 Buy Now: https://www.meticulousresearch.com/Checkout/73200843?utm_source=pdf&utm_medium =social&utm_campaign=product&utm_content=18-06-2024 About Meticulous Research Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Meticulous Research Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 3 of 3 Meticulous Research| sales@meticulousresearch.com